Picture of Xspray Pharma publ AB logo

XSPRAY Xspray Pharma publ AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: XSpray Pharma Gets Three New Patents In The U.S. For HyNap-Dasa

Feb 18 (Reuters) - XSpray Pharma AB (publ)  XSPRAY.ST :
    * THREE ADDITIONAL PRODUCT PATENTS IN THE US FOR HYNAP-DASA
    * UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) HAS
GRANTED
XSPRAY THREE NEW US PATENT FOR HYNAP-DASA.
    * NEW PATENTS, US10,561,643; US 10,561,644; AND
US10,561,645, ARE
VALID UNTIL JANUARY 2033

Source text for Eikon:  ID:nWkr4P6bmg 
Further company coverage:  XSPRAY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Xspray Pharma publ AB

See all news